Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Colestyramine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Colestyramine 4g oral powder sachets
0212000F0AAABAB
|
Colestyramine (Lipid lowering) | Colestyramine | Cardiovascular System | 18,376 |
|
Colestyramine 4g oral powder sachets sugar free
0212000F0AAAEAE
|
Colestyramine (Lipid lowering) | Colestyramine | Cardiovascular System | 16,320 |
|
Questran Light 4g oral powder sachets
0212000F0BBACAE
|
Questran | Colestyramine | Cardiovascular System | 9,723 |
|
Questran 4g oral powder sachets
0212000F0BBAAAB
|
Questran | Colestyramine | Cardiovascular System | 1,389 |
|
Colestyramine 10% cream
1303000E0AAAAAA
|
Colestyramine (Antipruritic) | Colestyramine | Skin | No data available |
|
Colestyramine 5% cream
1303000E0AAABAB
|
Colestyramine (Antipruritic) | Colestyramine | Skin | No data available |
|
Colestyramine 500mg/5ml oral liquid
0212000F0AAAGAG
|
Colestyramine (Lipid lowering) | Colestyramine | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.